OTC Brimonidine (Lumify) for Ocular Redness

Date: October 22, 2018 Issue #:  1558Summary:  The FDA has approved an over-the-counter (OTC) 0.025% ophthalmic formulation of the selective alpha2-adrenergic agonist brimonidine tartrate (Lumify– Bausch& Lomb) for treatment of ocular redness in adults and children≥5 years old. Lumify is the first brimonidine product to be approved for OTC use.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Alphagan Beta blockers brimonidine brimonidine/timolol Combigan Eye Lumify Oxymetazoline Source Type: research